ConductScience.org, home

Paper2014204

The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect.

Chen ML and 1 other. Pharm Res, 1991. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect. Papers, record 2014204. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2014204

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The role of metabolites in bioequivalency assessment. I. Linear pharmacokinetics without first-pass effect.
PubMed
Journal
Pharm Res
PubMed
Year
1991
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.96
iCite
Revised in PubMed
2026-10-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chen MLM L
2Jackson AJA J

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological AvailabilityMajor topic
PharmacokineticsMajor topic
Acetohexamide
Adolescent
Adult
Allopurinol
Analysis of Variance
Humans
Male
Middle Aged
Models, Biological
Procainamide
Sulindac

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13199316Primary, secondary, and tertiary metabolite kinetics.J Pharmacokinet Biopharm1988https://conductscience.org/library/papers/3199316PubMed
2799549Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.Clin Pharmacokinet1976https://conductscience.org/library/papers/799549PubMed
36759093Pharmacologically active metabolites of drugs and other foreign compounds. Clinical, pharmacological, therapeutic and toxicological considerations.Drugs1982https://conductscience.org/library/papers/6759093PubMed
43663884Prediction of steady-state bioequivalence relationships using single dose data I-linear kinetics.Biopharm Drug Dispos1987https://conductscience.org/library/papers/3663884PubMed
5546862Determination of sulindac and its metabolites in serum by high-performance liquid chromatography.J Chromatogr1979https://conductscience.org/library/papers/546862PubMed
67285558Conversational SAAM--an interactive program for kinetic analysis of biological systems.Comput Programs Biomed1981https://conductscience.org/library/papers/7285558PubMed
73450848A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability.J Pharmacokinet Biopharm1987https://conductscience.org/library/papers/3450848PubMed
8458558Clinical pharmacokinetics of procainamide infusions in relation to acetylator phenotype.J Pharmacokinet Biopharm1979https://conductscience.org/library/papers/458558PubMed
96174262N-Acetylprocainamide kinetics after single and repeated oral doses.Clin Pharmacol Ther1982https://conductscience.org/library/papers/6174262PubMed
103693579Controversy. II: Bioequivalence as an indicator of therapeutic equivalence: modeling the theoretic influence of bioinequivalence on single-dose drug effect.J Clin Pharmacol1987https://conductscience.org/library/papers/3693579PubMed
11762214High-performance liquid chromatographic assay for allopurinol and oxipurinol in human plasma.J Chromatogr1979https://conductscience.org/library/papers/762214PubMed
127299655High-performance liquid chromatographic assay of tolbutamide and carboxytolbutamide in human plasma.J Pharm Sci1981https://conductscience.org/library/papers/7299655PubMed
137048351Drug metabolite kinetics.Pharmacol Ther1981https://conductscience.org/library/papers/7048351PubMed
143626003Generic drugs and the prescribing physician.JAMA1987https://conductscience.org/library/papers/3626003PubMed
156362950First-pass elimination. Basic concepts and clinical consequences.Clin Pharmacokinet1984https://conductscience.org/library/papers/6362950PubMed
166157019Determination of procainamide and N-acetylprocainamide in biological fluids by high-pressure liquid chromatography.J Pharm Sci1980https://conductscience.org/library/papers/6157019PubMed
1714098474EXCRETION AND THE ACCRUAL OF DRUG METABOLITES.Nature1963https://conductscience.org/library/papers/14098474PubMed

Download CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
41350955
Utilizing Physiologically Based Pharmacokinetic Modeling and Virtual Simulation for Simvastatin Tablets to Evaluate the Sensitivity of Using Parent vs Metabolite as Analyte on Bioequivalence Assessment.
AAPS J2025https://conductscience.org/library/papers/41350955PubMed
20372987Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.Pharm Res2010https://conductscience.org/library/papers/20372987PubMed
18956142Equivalence-by-design: targeting in vivo drug delivery profile.Pharm Res2008https://conductscience.org/library/papers/18956142PubMed
18551249Bioavailability and bioequivalence: focus on physiological factors and variability.Pharm Res2008https://conductscience.org/library/papers/18551249PubMed
18349286Comparative bioavailability of sulindac in capsule and tablet formulations.Cancer Epidemiol Biomarkers Prev2008https://conductscience.org/library/papers/18349286PubMed
15244496Metabolites and bioequivalence: past and present.Clin Pharmacokinet2004https://conductscience.org/library/papers/15244496PubMed
9358562The pharmacokinetics of topotecan and its carboxylate form following separate intravenous administration to the dog.Pharm Res1997https://conductscience.org/library/papers/9358562PubMed
8481628Bioequivalence of allopurinol preparations: to be assessed by the parent drug or the active metabolite?Clin Investig1993https://conductscience.org/library/papers/8481628PubMed
7479556The role of metabolites in bioequivalency assessment. II. Drugs with linear pharmacokinetics and first-pass effect.Pharm Res1995https://conductscience.org/library/papers/7479556PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2014204

GET https://conductscience.org/api/papers/v1/2014204/authors